AlzeCure Pharma to Present at Aktiedagen in Stockholm on September 15
STOCKHOLM, SE / ACCESS Newswire / September 8, 2026 / AlzeCure Pharma AB (“AlzeCure” or “The Company”) (STO:ALZCUR)(FRA:AC6)…
Greenland Resources Receives Letter of Intent From Nordic Investment Bank
TORONTO, August 31, 2026–(BUSINESS WIRE)–Greenland Resources Inc. (TSX:MOLY | FSE:M0LY) (“Greenland Resources” or the “Company”) is pleased to…
Earnings Estimates Rising for A.P. Moller-Maersk (AMKBY): Will It Gain?
A.P. Moller-Maersk (AMKBY) could be a solid addition to your portfolio given a notable revision in the company’s…
Greenland Resources Provides Update
TORONTO, August 24, 2026–(BUSINESS WIRE)–Greenland Resources (TSX:MOLY | FSE: M0LY) (the “Company”) is pleased to provide an update…
Maine town to hold hearing on potential Poland Spring permit renewal
Maine town to hold hearing on potential renewal of Poland Spring’s water extraction permit DENMARK, Maine — The…
$1 Billion NYC-Startup Dash0 Acquires Berlin Tech Company to Build Software That Fixes Itself
The American software startup Dash0 is going on a shopping spree: the New York City-headquartered observability company, founded…
Tecno Entrepreneur Elvis Berlin Mouafo Eyes Downstream Oil Market With Elvi Energy
Cameroonian entrepreneur Elvis Berlin Mouafo has incorporated Elvi Energy SA to diversify from mobile telecommunications into the…
In order to resolve technical issues, trading in AB Novaturas shares on the Warsaw Stock Exchange is suspended
AB Novaturas AB Novaturas (hereinafter – the Company) hereby informs that on 20 July 2026, the Management Board…
Increase of the authorised capital of AB Novaturas is completed, new Articles of Association are registered, new shares are registered and introduced to trading on AB Nasdaq Vilnius
AB Novaturas AB Novaturas (hereinafter – the Company) announces that on 21 July 2026, (i) the Company’s amended…
Fangzhou Launches Novo Nordisk’s Once-Weekly Basal Insulin/GLP-1 Therapy in China
Fangzhou Inc. SHANGHAI, July 20, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a…
Fangzhou Launches Novo Nordisk’s Once-Weekly Basal Insulin/GLP-1 Therapy in China
Fangzhou Inc. SHANGHAI, July 20, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a…
Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal
Key Points Interested in Vivani Medical, Inc.? Here are five stocks we like better. Vivani Medical plans to…